HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC Emergency Contraceptive Restricted Access Supported By Gynetics Exec

This article was originally published in The Tan Sheet

Executive Summary

Age requirements and other restrictions would allow emergency contraceptives (ECs) to be safely sold OTC, Gynetics Chief Financial and Operating Officer Jack Stover stated at an FDA public meeting June 29.

You may also be interested in...



FDA-Initiated OTC Switches Could Be Based On Foreign Data – McClellan

FDA may rely on a drug's foreign OTC marketing experience to determine whether an Rx product should be switched OTC in the U.S. without sponsor consent, Commissioner Mark McClellan, MD/PhD, said at a Manhattan Institute roundtable discussion for buyside analysts May 16

Emergency Contraceptive Bill Passes Virginia House, Faces Senate Fight

A key amendment to legislation that would make emergency contraceptives available "behind-the-counter" in Virginia could limit the scope of the original bill, which cleared the House of Delegates Feb. 1.

Plan B Emergency Contraceptive Switch NDA Planned

Women's Capital Corporation will file an NDA next year to switch its Plan B emergency contraceptive to OTC status, the company said Dec. 13.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133638

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel